Barclays
HSTM icon

Barclays’s HealthStream HSTM Stock Holding History

Barclays’s Portfolio HSTM Stock Details HSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90.9K Sell
4,391
-32,741
-88% -$697K ﹤0.01% 4067
2025
Q4 		$857K Buy
37,132
+2,381
+7% +$59.9K ﹤0.01% 3546
2025
Q3 		$981K Sell
34,751
-12,298
-26% -$338K ﹤0.01% 3377
2025
Q2 		$1.3M Sell
47,049
-1,392
-3% -$41.1K ﹤0.01% 3157
2025
Q1 		$1.56M Sell
48,441
-13,002
-21% -$422K ﹤0.01% 2821
2024
Q4 		$1.95M Buy
61,443
+2,605
+4% +$80.4K ﹤0.01% 2902
2024
Q3 		$1.7M Buy
58,838
+34,821
+145% +$997K ﹤0.01% 2987
2024
Q2 		$670K Sell
24,017
-12,535
-34% -$334K ﹤0.01% 2845
2024
Q1 		$974K Sell
36,552
-16,288
-31% -$436K ﹤0.01% 3145
2023
Q4 		$1.43M Buy
52,840
+23,032
+77% +$572K ﹤0.01% 3178
2023
Q3 		$643K Buy
29,808
+985
+3% +$21.8K ﹤0.01% 2639
2023
Q2 		$708K Sell
28,823
-12,934
-31% -$321K ﹤0.01% 2538
2023
Q1 		$1.13M Buy
41,757
+12,732
+44% +$318K ﹤0.01% 2641
2022
Q4 		$721K Buy
29,025
+8,627
+42% +$207K ﹤0.01% 3057
2022
Q3 		$434K Sell
20,398
-1,032
-5% -$23.5K ﹤0.01% 2786
2022
Q2 		$465K Sell
21,430
-9,922
-32% -$198K ﹤0.01% 2917
2022
Q1 		$624K Sell
31,352
-10,706
-25% -$242K ﹤0.01% 2740
2021
Q4 		$1.11M Buy
42,058
+15,168
+56% +$401K ﹤0.01% 2766
2021
Q3 		$767K Sell
26,890
-6,563
-20% -$192K ﹤0.01% 2940
2021
Q2 		$934K Sell
33,453
-24,225
-42% -$609K ﹤0.01% 2699
2021
Q1 		$1.29M Sell
57,678
-8,548
-13% -$204K ﹤0.01% 2609
2020
Q4 		$1.45M Buy
66,226
+5,945
+10% +$119K ﹤0.01% 2495
2020
Q3 		$1.21M Buy
60,281
+15,856
+36% +$337K ﹤0.01% 2521
2020
Q2 		$984K Buy
44,425
+6,360
+17% +$147K ﹤0.01% 2782
2020
Q1 		$912K Sell
38,065
-723
-2% -$18.2K ﹤0.01% 3047
2019
Q4 		$1.05M Buy
38,788
+10,996
+40% +$302K ﹤0.01% 3631
2019
Q3 		$718K Sell
27,792
-4,768
-15% -$128K ﹤0.01% 3946
2019
Q2 		$842K Buy
32,560
+12,451
+62% +$327K ﹤0.01% 3865
2019
Q1 		$564K Buy
20,109
+10,498
+109% +$276K ﹤0.01% 4005
2018
Q4 		$232K Sell
9,611
-18,735
-66% -$486K ﹤0.01% 4474
2018
Q3 		$879K Buy
28,346
+11,762
+71% +$352K ﹤0.01% 3754
2018
Q2 		$454K Buy
16,584
+7,140
+76% +$189K ﹤0.01% 4038
2018
Q1 		$235K Buy
9,444
+2,958
+46% +$71.1K ﹤0.01% 4692
2017
Q4 		$150K Sell
6,486
-164
-2% -$3.86K ﹤0.01% 4924
2017
Q3 		$155K Buy
6,650
+548
+9% +$13K ﹤0.01% 4620
2017
Q2 		$160K Buy
6,102
+5,626
+1,182% +$155K ﹤0.01% 4548
2017
Q1 		$12K Buy
476
+120
+34% +$2.8K ﹤0.01% 6009
2016
Q4 		$9K Sell
356
-935
-72% -$24.1K ﹤0.01% 5934
2016
Q3 		$36K Sell
1,291
-2,810
-69% -$72.6K ﹤0.01% 5169
2016
Q2 		$109K Buy
+4,101
New +$96.4K ﹤0.01% 4344
2016
Q1 		– Sell
-2,383
Closed -$52K – 6254
2015
Q4 		$52K Buy
2,383
+2,176
+1,051% +$50.8K ﹤0.01% 4765
2015
Q3 		$5K Sell
207
-416
-67% -$11.1K ﹤0.01% 6046
2015
Q2 		$18K Sell
623
-13
-2% -$372 ﹤0.01% 5735
2015
Q1 		$16K Sell
636
-569
-47% -$15.5K ﹤0.01% 5946
2014
Q4 		$35K Sell
1,205
-909
-43% -$25.8K ﹤0.01% 5974
2014
Q3 		$50K Buy
2,114
+1,311
+163% +$33K ﹤0.01% 5883
2014
Q2 		$19K Sell
803
-4,131
-84% -$103K ﹤0.01% 6532
2014
Q1 		$129K Buy
4,934
+222
+5% +$6.59K ﹤0.01% 5216
2013
Q4 		$151K Sell
4,712
-5,552
-54% -$190K ﹤0.01% 5278
2013
Q3 		$380K Sell
10,264
-4,264
-29% -$139K ﹤0.01% 4407
2013
Q2 		$368K Buy
+14,528
New +$351K ﹤0.01% 4565

Other funds holding HSTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays's HSTM Position: Q1 2026 in Review

Barclays reduced its HealthStream (HSTM) stake by 88% in Q1 2026, selling an estimated $697K and leaving 4,391 shares worth $90.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4067.

Barclays first reported a position in HSTM in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.95M in Q4 2024. 197 funds tracked by Wall St. Rank hold HSTM as of Q1 2026.

  • Barclays held 4,391 shares of HealthStream worth $90.9K as of Q1 2026.
  • Barclays sold 32,741 HealthStream shares in Q1 2026, an estimated $697K.
  • HealthStream made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4067 holding.
  • Barclays first reported a position in HealthStream in Q2 2013 and has held it in 51 quarters since.
  • Barclays's HealthStream position peaked at $1.95M in Q4 2024.
  • 197 funds tracked by Wall St. Rank held HealthStream as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.